Curriculum Vitae
`
`
`Date: September 2020
`
`First Name:
`
`Reza
`
`Tabrizchi
`
`Memorial University, St. John’s, NL, Canada
`
`Division of BioMedical Sciences
`
`Medicine
`
`Professor (tenured Sep/1998)
`
`
`
`Surname:
`
`University:
`
`Department:
`
`Faculty:
`
`Present Rank:
`
`
`Post-Secondary Education:
`
`
`Degree
`B.Sc. (Hon.)
`M.Sc.
`
`Ph.D.
`
`Subject Area
`Pharmacology
`Pharmacology &
`Therapeutics
`Pharmacology &
`Therapeutics
`
`Dates
`1983
`1986
`
`1988
`
`University
`Sunderland, UK
`British Columbia,
`Canada
`British Columbia,
`Canada
`
`
`
`Professional Qualification:
`
`
`University
`Memorial, NL, Canada
`Calgary, AB, Canada
`British Columbia, BC, Canada
`British Columbia, BC, Canada
`Memorial, NL, Canada
`Memorial, NL, Canada
`Memorial, NL, Canada
`Memorial, NL, Canada
`
`Rank
`Post-Doctoral Fellow
`Post-Doctoral Fellow
`Research Fellow
`Assistant Professor
`Assistant Professor
`Associate Professor
`Professor
`Associate Dean, Research &
`Graduate Studies
`
`Dates
`Sep/1988-Jun/1990
`Jul/1990-Jul/1991
`Aug/1991-Jun/1992
`Jul/1992-Apr/1996
`May/1996-Aug/1998
`Sep/1998-Aug/2004
`Sep/2004-present
`Sep/2012-present
`
`
`
`Research and Scholarly Interests:
`
`
`
`Pharmacology of smooth muscle. Receptor mediated signal transduction and role of second
`
`messengers in control of vascular smooth muscle tone
`
`
`Regulatory mechanisms involved in control of the cardiovascular system
`
`
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 1 of 17
`
`

`

`Tabrizchi, R.
`
`The role of systemic capacitance blood vessels in control of venous return and cardiac output.
`
`Actions of drugs on circulation in pathophysiological states: hypertension, haemorrhagic shock, non-
`haemorrhagic shock, and heart failure
`
` Molecular mechanism of drugs on cardiac tissues and drug adverse effects and toxicity associate
`with myocardium
`
`
`Teaching:
`
`I have been involved in teaching in the discipline of pharmacology. I have taught basic
`
`pharmacology both at the undergraduate and graduate levels. The subject matter that I have taught
`includes, drug absorption, distribution, excretion, and metabolism, quantitative aspects of
`pharmacokinetics, drug interactions, actions of drugs on autonomic nervous system, antihypertensive
`drugs, anti-anginal drugs, drugs in treatment of heart failure, lipid lowering drugs, antiarrhythmic agents,
`diuretics, drugs that affect the gastrointestinal system, drugs acting as muscle relaxants, and
`pharmacology of eicosanoids.
`
`I have taught in following courses at UBC: Pharmacology 302 (91-96), 305 (91-96), 402 (91-96),
`
`404 (91-96), 538A (92-95), 500 (94-95) 425 (95-96) and Neuroscience 500 (94-95), and at Memorial
`University: Medicine 3090 (96-99), 4000 (96-97), 6190 (99-05), 4300 (96-18), 5600 (99-13),
`Pharmacy 4009 (98-03), Phase 2 & 3 (14-20), and Pharmacy 3805 (18-20).
`
`
`Supervision, Training and Mentorship of Highly Qualified Personnel
`
` have been responsible for the training, (as an advisor) and mentoring of number of Highly Qualified
`Personnel (HQP) as graduate students (Master and Doctoral), medical residents, undergraduate (honours
`& summer students) and research assistants.
`
` I
`
` I
`
` have also served on the academic supervisory committees of numerous students (Master and Doctoral),
`as well as been examiner for graduate and undergraduate thesis and oral comprehensive exams of
`doctoral students.
`
`
`Services and Committees:
`
`As an academic and administrator, I have served on a number committee during my tenure as a
`professor,
`
`Life Sciences Library Committee (UBC)
`Pharmacology Course 402 (UBC) (Co-Chair)
`Pharmacological Society of Canada (PSC) Nominating Committee
`Basic Science of Medicine II Committee
`MUNFA Executive Committee
`MUNFA Scholarship Committee
`Committee to Review the Structure of the Division of Basic Medical Sciences
`Research & Development Committee (Medicine)
`Basic Sciences Faculty Search Committee
`Faculty Executive Committee (Medicine)
`Promotion and Tenure Committee (Medicine)
`
`-2-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 2 of 17
`
`

`

`Tabrizchi, R.
`
`Basic Sciences Search Committee for Associate Dean
`Sub-Committee for Accreditation (Medical School Admissions)
`Pharmacological Society of Canada Nominating Committee
`Pharmacology Advisory Committee
`Heart and Stroke Foundation of Canada Grant Review Committee II
`Committee of Undergraduate Studies (School of Pharmacy)
`Constitution and Bylaws Committee
`Promotion and Tenure Committee - Medicine (Chair)
`Canadian Journal of Physiology and Pharmacology Awards Committee (PSC)
`Academic Council, School of Pharmacy
`BioMedical Sciences Search Committee for Associate Dean
`Promotion and Tenure Committee - School of Pharmacy
`Integrated Basic, Community Health and Clinical Sciences Course (Chair)
`Clerkship Committee
`Admissions Committee (Medicine)
`Discipline of Genetics Faculty Search Committee
`Heart and Stroke Foundation of Canada Grant Review Committee IVc
`School of Pharmacy Faculty Search Committee
`Program Evaluation Sub-Committee (Medicine)
`Admissions Committee (Medicine)
`Committee to Review Assistant Dean for Admissions (Medicine)
`Pharmacology Subject Chair
`Sub-Committee Admissions, Interview (Medicine)
`Member of Steering Committee of Accreditation (Medicine)
`Student Promotions Committee, Chair (Medicine)
`Memorial University CRC Steering Committee
`Memorial University Research Data Centre Management Committee
`Memorial University CFI Innovation Fund Selection Committee
`Memorial University CFI JELF Selection Committee
`AFMC Research & Graduate Committee
`Memorial University Research Data Centre Management Board
`Memorial University SafetyNet Board
`Discipline of Anesthesia Resident Research Forum Adjudicating Committee
`Memorial University Fogo Island Research Fellowship Committee
`Memorial University Summer Student Internship Program Selection Committee
`Dean of Medicine Transition Fund (Chair)
`Vice-President (Research) Search Committee
`Student Appeals Committee, (Medicine)
`ROMOE Implementation Steering Committee
`Memorial University Innovation Strategy Advisory Committee
`FoM 50th Anniversary Celebration Committee (co-Chair)
`Memorial University SBM Fund Adjudicating Committee
`Dean of HKR Search Committee (Memorial University)
`Graduate Studies and Research Committee (School of Pharmacy)
`Discipline of Anesthesia Research Committee
`Senior Management Committee (Medicine)
`Medical Research Foundation Board (Medicine)
`Memorial University Research Council
`Faculty of Medicine Space Committee
`Memorial University Advisory Awards Committee
`Awards Committee, Chair (Medicine)
`
`-3-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 3 of 17
`
`

`

`Tabrizchi, R.
`
`AFMC Research Committee
`Faculty Development Committee
`Animal Resources Centre Steering Committee
`Innovation Coordination Committee
`Memorial University Research IT Committee
`Memorial University PHIA Implementation Committee
`Health Innovation Initiative Advisory Board
`Faculty of Medicine Senior Executive Committee
`Destination Excellence Implementation Steering Team (DEIST)
`Team Project Research – DEIST (co-Chair)
`NL Aging Research Centre Management Board
`BioMedical Sciences Faculty Search Committee
`Memorial University Research Pandemic Sub-Committee
`Faculty of Medicine COVID-19 Task Force
`
`
`Other Service Activities:
`
`
`
`
`Adjudications of Posters of Trainees for Canadian Hypertension Society
`Adjudications of presentation of research and scholarly work by anesthesia residents, Discipline
`of Anesthesia Research Forum, FoM, Memorial University
`Adjudications of Posters of Trainees, School of Pharmacy (MUN) Research Day
`
` Moderator for Health Professional Panels at Discovery Day in Health Sciences
` Member of Professional Panel for Project Pulse NL
`
`Adjudications of Posters of Trainees for Canadian Society for Pharmaceutical Sciences
`
`Scholarly Activities and Research Funding:
`
`Received research funding as the principal investigator for over two decades from charitable
`
`organization and national grant agencies in Canada
`
`Professional Development (e.g., trainings, workshops)
`
`
`
`Attendance at American Medical Association (AMA) meeting in Chicago, IL, on medical
`education and workshop on medical school accreditation)
`Physician Management & Leadership Program
`
`SSHRC-CIHR Workshop
`
`Intellectual Property Workshop & Case Study
`
` Workshop - Faculty of Medicine Admission - Situational Judgement Test- Admissions
` Workshop - Making MUN More Innovative
` Workshop - Information Technology Governance Collaboration
` Workshop - Development of Interprofessional Education Facilitation Skills
`
`Project Management Workshop, Office Professional Education and Development
` Workshop for CRC unconscious biased training, and completion of the module
`
`
`Membership of Societies:
`
`
`
`
`
`
`American Society for Pharmacology and Experimental Therapeutics
`British Pharmacological Society
`Canadian Hypertension Society
`
`-4-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 4 of 17
`
`

`

`Tabrizchi, R.
`
`
`Reviewer:
`
`periodicals and journals:
`
`Annals of Cardiothoracic Surgery
`
`BioMed Central
`
`British Journal of Pharmacology
`
`Canadian Journal of Physiology and Pharmacology
`
`Cardiovascular Research
`
`Drug Development Research
`
`European Journal of Pharmacology
`
`Intensive Care Medicine
`
`Journal of Cardiovascular Pharmacology
`
`Journal of Pharmacological & Toxicological Methods
`
`Journal of Pharmacy and Pharmacology
`
`Life Sciences
`
`Pharmacological Research
`
`Pharmacology & Therapeutics
`
`Sports Medicine
`
`The American Journal of Medicine
`
`The Canadian Journal of Cardiology
`
` peer-review between 16-18 manuscripts per year
`
` I
`
`
`Agencies:
`
`Heart and Stroke Foundation of Canada
` Medical Research Council/Canadian Institute for Health Research
`
`Swiss National Science Foundation
`
`Natural Sciences and Engineering Research Council of Canada
`
`College of Medicine, University of Saskatchewan
`
`
`Editor-in-Chief
`
`
`
`
`Editorial Board
`
`
`
`
`
`
`
`Awards:
`
`
`
`
`
`
`
`1984-1987 B.C. Heart Foundation Traineeship
`1987-1988 UBC Graduate Fellowship
`1988-1990 Canadian Heart Foundation Fellowship
`1990-1991 Medical Research Council Fellowship
`1992-1997 Heart and Stroke Foundation of Canada Scholarship
`
`Vascular Health and Risk Management (2004-2006)
`
`Expert Review of Cardiovascular Therapy (2002-2014)
`BioMed Central – Pharmacology and Toxicology (2013-2015)
`Journal of Pharmacological & Toxicological Methods (2002-present)
`Vascular Health and Risk Management (2006-present)
`Journal of Cardiovascular Pharmacology (2015-present)
`
`-5-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 5 of 17
`
`

`

`Tabrizchi, R.
`
`Publications:
`
`(a)
`
`1. Curtis, M.J., MacLeod, B.A., Tabrizchi, R. and Walker, M.J.A. An improved perfusion apparatus
`for small animal hearts. J. Pharmacol. Methods, 15:87-94, 1986.
`
`Refereed Publications (Original Work)
`
`
`2. Pang, C.C.Y. and Tabrizchi, R. The effects of noradrenaline, B-HT 920, methoxamine, angiotensin
`II and vasopressin on mean circulatory filling pressure in conscious rats. Br. J. Pharmacol. 89:389-
`394, 1986.
`
`
`3. Tabrizchi, R., King, K.A. and Pang C.C.Y. Vascular role of vasopressin in the presence and absence
`of influence from angiotensin II or α-adrenergic system. Can. J. Physiol. Pharmacol. 64:1143-
`1148,1986.
`
`
`4. Tabrizchi, R. and Pang, C.C.Y. Comparative effects of rauwolscine, prazosin, and phentolamine on
`blood pressure and cardiac output in anesthetized rats. Can. J. Physiol. Pharmacol. 65:1421-1427,
`1987.
`
`
`5. Tabrizchi, R. and Pang, C.C.Y. Are angiotensin receptors in vascular smooth muscles a
`homogeneous population? Eur. J. Pharmacol. 142:359-366, 1987.
`
`
`6. King, K.A., Tabrizchi, R. and Pang, C.C.Y. Investigation of the central and peripheral actions of
`clonidine and methoxamine using a new in vivo rat preparation. J. Pharmacol. Methods, 17:283-
`295, 1987.
`
`
`7. Tabrizchi, R., Moore, G.J. and Pang, C.C.Y. [Sar1 Ile7]Angiotensin III, a new selective antagonist
`of the pressor effects of angiotensin III in conscious rats. Life Sci. 43:537-543, 1988.
`
`
`8. Tabrizchi, R. and Pang, C.C.Y. Pressor responses to β1- and β2-blockers in conscious rats treated
`with phentolamine. Pharmacology, 37:385-393, 1988.
`
`
`9. D'Oyley, H.M., Tabrizchi, R. and Pang, C.C.Y. Effect of vasodilator drugs on venous tone in
`conscious rats. Eur. J. Pharmacol. 162:337-344, 1989.
`
`
`10. Tabrizchi, R. and Pang, C.C.Y. Propranolol antagonizes hypotension induced by α-blocker but
`not by sodium nitroprusside or methacholine. Can. J. Physiol. Pharmacol. 67:83-87, 1989.
`
`
`11. Tabrizchi, R., Pang, C.C.Y. and Walker, M.J.A. Effects of anipamil on cardiovascular status and
`regional blood flow in anaesthetized rats. Br. J. Pharmacol. 98:1185-1190, 1989.
`
`
`12. Tabrizchi, R. and Triggle, C.R. Benextramine and nifedipine distinguish between two classes of
`α1-adrenoceptors. Life Sci. 45:2577-2585, 1989.
`
`
`13. Abdelrahman, A., Tabrizchi, R. and Pang C.C.Y. Effects of β1- and β2-adrenoceptors stimulation
`on haemodynamic in the anaesthetized rat. J. Cardiovasc. Pharmacol. 15:720-728, 1990.
`
`
`14. Tabrizchi, R. and Triggle, C.R. Comparison between the actions of endothelin and vasopressin in
`the pithed rats after pretreatment with BAY K 8644, nifedipine or pertussis toxin. J. Pharmacol. Exp.
`Ther. 253:272-276, 1990.
`
`
`15. Tabrizchi, R. and Triggle, C.R. Effects of nifedipine, BAY K 8644 and pertussis toxin on pressor
`response to sarafotoxin-b in pithed rats. J. Cardiovasc. Pharmacol. 16:495-500, 1990.
`
`-6-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 6 of 17
`
`

`

`Tabrizchi, R.
`
`
` Tabrizchi, R. and Pang, C.C.Y.
` Adrenalectomy abolishes antagonism of α-
`16.
`adrenoceptors-mediated hypotension by a β-blocker in conscious rats. Br. J. Pharmacol. 101:358-
`362, 1990.
`
`
`17. Tabrizchi, R. and Triggle, C.R. Effects of endothelin 3 on diastolic blood pressure of pithed
`Sprague-Dawley, Wistar-Kyoto and Spontaneously Hypertensive rats before and after pretreatment
`with nifedipine. Can. J. Physiol. Pharmacol. 69:531-535, 1991.
`
`
`18. Tabrizchi, R. and Triggle, C.R. Pressor actions of arginine vasopressin in pithed Sprague-Dawley,
`Wistar-Kyoto and Spontaneously hypertensive rats before and after treatment with nifedipine or
`pertussis toxin. J. Hypertension, 9:813-818, 1991.
`
`
`19. Tabrizchi, R. and Triggle, C.R. Effects of staurosporine on pressor actions of α-adrenoceptor
`agonists in pithed rats: A comparison with nifedipine. Pharmacology, 43:128-140, 1991.
`
`
`20. Tabrizchi, R. and Triggle, C.R. Influence of N-nitro-L-arginine methyl on pressor responses
`elicited by sympathetic nerve stimulation in pithed normotensive and hypertensive rats. Life Sci.
`49:1989-1995, 1991.
`
`
`21. Triggle, C.R. and Tabrizchi, R. Effects of in vivo treatment with pertussis and cholera toxins on
`pressor effects mediated by α-adrenoceptor agonists and vasopressin: Changes in hypertension. J.
`Vasc. Med. Biol. 3:197-204, 1991.
`
`
`22. Tabrizchi, R. and Triggle C.R. Actions of L- and D-arginine and NGmonomethyl-L-arginine on
`diastolic blood pressure of pithed normotensive and hypertensive rats. Clin. Exp. Hyper.-Theory &
`Practice, A14:527-546, 1992.
`
`
`23. Tabrizchi, R. and Triggle, C.R. The interrelationship between the effects of captopril and
`nifedipine on pressor responses elicited by selective α-adrenoceptor agonists in the pithed rat
`preparation. J. Cardiovasc. Pharmacol. 19:562-567, 1992.
`
`
`24. Tabrizchi, R. King, K.A. and Pang, C.C.Y. Direct and indirect effects of angiotensin II on mean
`circulatory filling pressure in the conscious rat. Eur. J. Pharmacol. 219:141-145, 1992.
`
`
`25. Tabrizchi, R. and Triggle, C.R. Comparison of the effects of acute versus chronic administration
`of phenoxybenzamine on pressor responses elicited by the selective α1-adrenoceptor agonist
`cirazoline in the pithed rat preparation. Can. J. Physiol. Pharmacol. 70:916-921, 1992.
`
`
`26. Tabrizchi, R. and Pang, C.C.Y. Influence of intravenous infusion of ethanol on haemodynamics
`and regional blood flow of conscious rats. J. Pharm. Pharmacol. 45:151-153, 1993.
`
`
`27. Triggle , C.R. and Tabrizchi, R. Changes in vascular smooth muscle function in hypertension.
`Chin. Med. J. 106:250-257, 1993.
`
`
`28. Tabrizchi, R., Lim, S.U. and Pang, C.C.Y. Possible equilibration of portal venous and central
`venous pressure during circulatory arrest. Am. J. Physiol. 264:H259-H261, 1993.
`
`
`29. Tabrizchi, R. and Triggle, C.R. Pressor responses to the selective α1-adrenoceptor agonist
`cirazoline: effects of captopril, phenoxybenzamine and/or nifedipine. Eur. J. Pharmacol. 251:15-
`20, 1994.
`
`
`30. Adeaghbo, A.S.O., Tabrizchi, R. and Triggle, C.R. The effects of Nw-nitro-L-arginine methyl
`
`-7-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 7 of 17
`
`

`

`Tabrizchi, R.
`
`ester (L-NAME) on responses to pressor agents in the isolated perfused mesenteric arterial bed of
`normotensive and spontaneously hypertensive rats. Br. J. Pharmacol. 111:13-20, 1994.
`
`
`31. Tabrizchi, R. Effects of chronic receptor blockade on excitation-contraction coupling in rat aortic
`rings. Eur. J. Pharmacol. 259:285-293, 1994.
`
`
`32. Tabrizchi, R., Role of intracellular and extracellular calcium in α1-adrenoceptor mediated
`vasoconstriction in the rat perfused hindquarters. Arch. Inter. Pharmcody. 328:26-38, 1994.
`
`
`33. Tabrizchi, R., MacNicol B.J. and Lin, B.P. Effects of organic and inorganic calcium channel
`antagonists and pertussis toxin on noradrenaline-induced contractions in pulmonary artery from
`pulmonary hypertensive rats. Life Sci. 56:1173-1185, 1995.
`
`
`34. Tabrizchi, R. The influence of non-peptide angiotensin antagonist, losartan, on neurogenic
`vasoconstriction. J. Cardiovasc. Pharmacol. 25:717-723, 1995.
`
`
`35. Tabrizchi, R. and Lupichuk, S.M. The effects of losartan and captopril on vasopressor actions of
`cirazoline in the absence and presence of SZL-49 and nifedipine. J Cardiovasc. Pharmacol. 26:137-
`144, 1995.
`
`
`36. Lum Min, S.A. and Tabrizchi, R. Effects of 8-bromoguanosine 3’:5’-cyclic monophosphate on
`phenylephrine induced phosphatidylinositol hydrolysis and contraction in rat caudal artery. Br. J.
`Pharmacol. 116:1697-1703, 1995.
`
`
`37. Tabrizchi, R. and Lupichuk, S.M. Vasodilatation produced by adenosine in isolated rat perfused
`mesenteric artery: A role for endothelium. Naunyn-Schmiedeberg’s Arch. Pharmacol. 352:412-
`418, 1995.
`
`
`38. Nekooeian, A.A. and Tabrizchi, R. Effects of adenosine A2A receptor agonist, CGS 21680, on
`blood pressure, cardiac index and arterial conductance in anaesthetized rats. Eur. J. Pharmacol.
`307:163-169, 1996.
`
`
`39. Lum Min, S.A. and Tabrizchi, R. Regulation of intracellular Ca2+ by 8-bromoguanosine 3’:5’-
`cyclic monophosphate, felodipine and ryanodine in rat caudal artery. Eur. J. Pharmacol. 318:97-
`100, 1996.
`
`
`40. He, Y. and Tabrizchi, R. Effects of niflumic acid on α1-adrenoceptor induced vasoconstriction in
`mesenteric artery in vitro and in vivo in two-kidney one-clip hypertensive rats. Eur. J. Pharmacol.
`328:191-199, 1997.
`
`
`41. Tabrizchi, R. Effects of adenosine and adenosine analogues on mean circulatory filling pressure
`and cardiac output in anesthetized rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 356:69-75,
`1997.
`
`
`42. Nekooeian, A.A. and Tabrizchi, R. Effects of CGS 21680, a selective A2A adenosine receptor
`agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetised rat. Br.
`J. Pharmacol. 123:1666-1672, 1998.
`
`
`43. Nekooeian, A.A. and Tabrizchi, R. Haemodynamic effects of selective A2A adenosine receptor
`agonist, CGS 21680, in chronic heart failure in the anaesthetised rat. Br. J. Pharmacol. 125:651-
`658, 1998.
`
`-8-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 8 of 17
`
`

`

`Tabrizchi, R.
`
`
`44. Tabrizchi, R. Cardiovascular effects of noradrenaline in hypovolemic haemorrhage: role of
`inducible nitric oxide synthase. Eur. J. Pharmacol. 361:227-234, 1998.
`
`
`45. Lum Min, S.A., Stapleton, M.P. and Tabrizchi, R. Influence of chloride ions on α1-adrenoceptor
`mediated contraction and Ca2+ influx in rat caudal artery. Life Sci. 64:1631-1641, 1999.
`
`
`46. Tabrizchi, R. Influence of increase in osmotic pressure with sucrose on relaxation and
`cyclonucleotides levels in isolated rat aorta. Eur. J. Pharmacol. 382:177-185, 1999.
`
`
`47. Duggan, J.A. and Tabrizchi, R. Influence of T-type Ca2+ (mibefradil) and Cl- (indanyloxacetic
`acid 94) channel antagonists on α1-adrenoceptor mediated contraction in rat aorta. Can. J. Physiol.
`Pharmacol. 78:714-720, 2000.
`
`
`48. Tabrizchi, R. and Duggan, J.A. The interrelationship between chloride ions and endothelium on
`α1-adrenoceptor-mediated contractions in aortic rings from Dahl normotensive and hypertensive rats.
`Cardiovasc. Res. 48:393-401, 2000.
`
`
`49. Tabrizchi, R. The influence of tumour necrosis factor-α on the cardiovascular system of
`anaesthetized rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 363:307-321, 2001.
`
`
`50. Dutta, P., Ryan, D.E. and Tabrizchi, R. The influence of phosphodiesterase inhibitor, rolipram, on
`haemodynamics in lipopolysaccharide-treated rats. Jap. J. Pharmacol. 85:241-249, 2001.
`
`
`51. Duggan, J.A. and Tabrizchi, R. Effect of nitric oxide synthase inhibitor Nω nitro-L-arginine methyl
`ester on relaxant responses to calcium channel antagonists in isolated aortic rings from Dahl
`normotensive and hypertensive rats. J. Cardiovasc. Pharmacol. 39:354-362, 2002.
`
`
`52. Parai, K. and Tabrizchi, R. A comparative study of the effects of Cl- channel blockers on
`mesenteric vascular conductance in anaesthetized rat. Eur. J. Pharmacol. 448:59-66, 2002.
`
`
`53. Mong, K., Duggan, J.A. and Tabrizchi, R. Comparative study of functional responses and
`morphometric state of distal radial arteries in male and female. Annal Thorac Surg. 74:2126-2131,
`2002.
`
`
`54. Tabrizchi, R. and Ford, C.A. Haemodynamic effects of endothelin receptor antagonist, tezosentan,
`in tumour necrosis factor-α treated anaesthetized rats. Naunyn-Schmiedeberg’s Arch. Pharmacol.
`367:156-167, 2003.
`
`
`55. Duggan, J.A., Mong, K. and Tabrizchi, R. The influence of calcium channel antagonists on isolated
`human distal radial arteries. J. Cardiovasc. Pharmacol. 42:629-635, 2003.
`
`
`56. Bieger, D., Duggan, J.A. and Tabrizchi, R. Effects of chloride substitution on electromechanical
`responses in the pulmonary artery of Dahl normotensive and hypertensive rats. Br. J. Pharmacol.
`141:1068-1076, 2004.
`
`
`57. Tabrizchi, R., Ford, C.A. A comparison between haemodynamic effects of vasopressin analogues.
`Naunyn-Schmiedeberg’s Arch. Pharmacol. 370:340-346, 2004.
`
`
`58. Parai, K. and Tabrizchi, R. Impact of nitric oxide synthase inhibitor and chloride channel
`antagonist on mesenteric vascular conductance in anaesthetized Dahl normotensive rats. J.
`
`-9-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 9 of 17
`
`

`

`Tabrizchi, R.
`
`Cardiovasc. Pharmacol. 45:569-579, 2005.
`
`
`59. Parai, K. and Tabrizchi, R. Effects of chloride substitution in isolated mesenteric blood vessels
`from Dahl normotensive and hypertensive rats. J. Cardiovasc. Pharmacol. 46:105-114, 2005.
`
`
`60. Ford, C.A. Bieger, D., Mong, K. and Tabrizchi, R. Relaxant responses to calcium channel
`antagonists and potassium channel opener in human saphenous vein. Autonomic & Autacoid
`Pharmacol. 26:1-6, 2006.
`
`
`61. Bieger, D., Mong, K. and Tabrizchi, R. Anomalous response to potassium in vascular smooth
`muscle cells of human saphenous vein. Autonomic & Autacoid Pharmacol. 26:7-13, 2006.
`
`
`62. Bieger, D., Parai, K., Ford, C.A. and Tabrizchi, R. β-adrenoceptor mediated responses in rat
`pulmonary artery: putative role of TASK-1 related K channels. Naunyn-Schmiedeberg’s Arch.
`Pharmacol. 373:186-196, 2006.
`
`
`63. Ford, C.A., Mong, K. and Tabrizchi, R. Influence of tangential stress on mechanical responses to
`vasoactive agents in human saphenous vein with and without perivascular adipose tissue. Can. J.
`Cardiol. 22:1209-1216, 2006.
`
`
`64. Guo, L. and Tabrizchi, R. Haemodynamic effects of vasoactive agents following chronic state of
`high cardiac output in anaesthetized rats. Eur. J. Pharmacol. 586:266-274, 2008.
`
`
`65. Bieger, D., Ford, C.A., Mong, K. and Tabrizchi, R. Transmural pressure and membrane potential
`in human saphenous vein. Eur. J. Cardiothorac. Surg. 34:109-112, 2008.
`
`
`66. Tabrizchi, R. and Ford, C.A. Alteration in hemodynamic effects of interleukin 2 after treatment
`with indomethacin in anesthetized rats. Vasc. Pharmacol. 52:230-235, 2010.
`
`
`67. Mahajan, P. and Tabrizchi, R. Influence of endothelium on β-adrenoceptor-mediated mechanical
`and electrical function in rat pulmonary artery. Vascul. Pharmacol. 53:144-150, 2010.
`
`
`68. Burke, M., Bieger, B. and Tabrizchi, R. Agonist-induced vasomotion in rat isolated pulmonary
`artery. Fund. Clin. Pharmacol., 25:443-451, 2011.
`
`
`69. Ford, C.A., Mahajan, P. and Tabrizchi, R. Characterization of β-adrenoceptor-mediated relaxation
`signals in isolated pulmonary artery of Dahl salt-sensitive hypertensive and normotensive rats.
`Autonomic & Autacoid Pharmacol. 31:1-12, 2011.
`
`
`70 Bieger, D., Ford, C.A. and Tabrizchi, R. Potassium-induced periodic vasomotion in rat isolated
`pulmonary artery. J. Smooth Muscle Res. 47:21-35, 2011.
`
`
`71 Duggan, D.J., Bieger, D. and Tabrizchi, R. Neurogenic responses in rat and porcine large
`pulmonary arteries. Pulm. Cric. 1:419-424, 2011.
`
`
`72. Mahajan, P. and Tabrizchi, R. Influence of hyperpolarization caused by high salt diet on β-
`adrenoceptor mediated responses in rat pulmonary artery. J. Cardiovasc. Pharmacol. 60:23-32,
`2012.
`
`
`73. Macala, K. and Tabrizchi, R. The effect of fat emulsion on hemodynamics following treatment
`with propranolol and clonidine in anesthetized rats. Acad. Emg. Med. 21:1220-1225, 2014.
`
`-10-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 10 of 17
`
`

`

`Tabrizchi, R.
`
`
`74. Duggan, D.J. and Tabrizchi, R. Angiotensin II control of regional haemodynamics in rats with
`aortocaval fistula. Exp. Physiol. 101:1192-1205, 2016.
`
`
`75. Foto Soh, J., Strong, H.R., Daneshtalab, N. and Tabrizchi, R. The effect of
`inflammation on sympathetic nerve mediated contractions in rat isolated caudal artery.
`Eur. J. Pharmacol. 792:54-62, 2016.
`
`
`76. Leblanc, C., Strong, H.R. and Tabrizchi, R. Evaluation of different metrics as an index
`for the assessment of arterial stiffness. Clin. Exp. Hypertens. 40:390-397, 2018.
`
`
`77. Leblanc, C. and Tabrizchi, R. Role of β2- and β3-adrenoceptors in arterial stiffness in a
`state of hypertension. Eur. J. Pharmacol. 819:136-143, 2018.
`
`
`
`(b)
`
`1. Tabrizchi, R. and Pang, C.C.Y. Influence of α1- and/or α2-adrenoceptors antagonists on regional
`distribution of cardiac output. Can. Fed. Biol. Soc., 1985.
`
`Conferences Proceedings:
`
`
`2. Tabrizchi, R., King, K.A. and Pang, C.C.Y. Vascular role of vasopressin in the presence and absence
`of influences from angiotensin II and/or α-adrenergic system. Western Pharmacological Society,
`1986.
`
`
`3. Tabrizchi, R. and Pang, C.C.Y. The role of α-adrenoceptors in the control of mean circulatory
`filling pressure in conscious rats. XXX Congress of International Union of Physiological Sciences,
`1986.
`
`
`4. Pang, C.C.Y., King, K.A and Tabrizchi, R. A new in vivo technique to separate completely the
`central and peripheral cardiovascular actions of drugs. XXX Congress of International Union of
`Physiological Sciences, 1986.
`
`
`5. King, K.A., Tabrizchi, R. and Pang, C.C.Y. Investigation of central and peripheral effects of
`clonidine and methoxamine using a new cross-circulation technique. Hypertension Satellite XXX
`Congress of International Union of Physiological Sciences, 1986.
`
`
`6. Tabrizchi, R., King, K.A. and Pang, C.C.Y. Paradoxical hypertension associated with β-blockers.
`Can. Fed. Biol. Soc., 1987.
`
`
`7. Tabrizchi, R. and Pang, C.C.Y. Are angiotensin receptors a homogeneous population? ASPET,
`1987.
`
`
`8. Tabrizchi, R. and Pang, C.C.Y. Antagonism by propranolol of hypertension induced by α-blockers.
`FASEB, 2:A327, 1988.
`
`
`9. Walker, M.J.A., Tabrizchi, R. and Pang, C.C.Y. Effects of anipamil on haemodynamics and regional
`blood flow in anesthetized rats. FASEB, 2:A796, 1988.
`
`
`10. D'Oyley, H.M., Tabrizchi, R. and Pang, C.C.Y. Effect of non-specific vasodilators on blood
`pressure and venous tone in conscious rats. FASEB, 2:A1792, 1988.
`
`-11-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 11 of 17
`
`

`

`Tabrizchi, R.
`
`
`11. Tabrizchi, R. and Pang, C.C.Y. Direct and indirect effects of angiotensin II on mean circulatory
`filling pressure in the conscious rat. FASEB, 2:A796, 1989.
`
`
`12. Tabrizchi, R. and Triggle, C.R. Do benextramine and nifedipine differentiate between two classes
`of α1-adrenoceptors? Can. Fed. Biol. Soc., 1989.
`
`13. Tabrizchi, R. and Triggle, C.R. Comparison between the actions of endothelin and vasopressin in
`the pithed rats after pretreatment with BAY K 8644, nifedipine or pertussis toxin. Society for
`Neuroscience, 1989.
`
`
`14. Triggle, C.R. and Tabrizchi, R. Vasoactive actions of arginine vasopressin in pithed
`Sprague-Dawley, Wistar Kyoto and Spontaneously hypertensive rats after pretreatment with
`nifedipine or pertussis toxin. Vascular Neuroeffector Mechanisms 7th International Symposium
`IUPHAR, 1990.
`
`
`15. Triggle, C.R. and Tabrizchi, R. Actions of L- and D-arginine and NGmonomethyl-L-arginine on
`diastolic blood pressure of pithed normotensive and hypertensive rats. Western Pharmacology
`Society, 1991.
`
`
`16. Tabrizchi, R. and Triggle, C.R. Effects of pertussis and cholera toxins on vasoactive actions of
`full and partial α1-agonists. FASEB, 5:A1596, 1991.
`
`
`17. Triggle, C.R. and Tabrizchi, R. A comparison between the inhibitory actions of staurosporine and
`nifedipine on α-mediated vasoconstriction. FASEB, 5:A1043, 1991.
`
`
`18. Tabrizchi, R. and Triggle, C.R. Effects of acute versus chronic phenoxybenzamine treatment on
`pressor responses elicited by the selective α1-adrenoceptor agonist cirazoline. Can. Fed. Biol. Soc.,
`1991.
`
`
`19. Triggle, C.R. and Tabrizchi, R. Effects of in vivo treatment with pertussis and cholera toxins on
`pressor effects mediated by α-adrenoceptor agonists and vasopressin: Changes in hypertension.
`Calcium and Gene Hypertension Symposium, Portland, Org, July 1991.
`
`
`20. Triggle, C.R. and Tabrizchi, R. Role of endothelial cell dysfunction in spontaneously hypertensive
`rats: A question of vasoconstriction or vasodilatation. Canadian Cardiovascular Society, 1991.
`
`
`21. Tabrizchi, R. and Triggle, C.R. Interaction between angiotensin II and sub-types of α1-
`adrenoceptors. Society for Neuroscience, 1991.
`
`
`22. Triggle, C.R. and Tabrizchi, R. Changes in vascular smooth muscle function in hypertension - role
`of altered signal-transduction processes. Hypertension and Coronary Heart Disease Symposium,
`Beijing, China, Oct. 1991.
`
`
`23. Triggle, C.R. and Tabrizchi, R. α-mediated vasoconstriction: Transmembrane signaling and
`receptor reclassification. Adv. Exp. Med. Biol. 311:397-398, 1992.
`
`
`24. Pang, C.C.Y. and Tabrizchi, R. Possible equilibration of central venous pressure and portal venous
`pressure during the determination of mean circulatory filling pressure in conscious and anesthetized
`rats. Can. Fed. Biol. Soc., 1992.
`
`
`25. Tabrizchi, R. and Pang, C.C.Y. Role of calcium in α1-adrenoceptor-mediated vasoconstriction in
`perfused rat hindquarters. Can. Fed. Biol. Soc., 1992.
`
`
`
`-12-
`
`NOVARTIS EXHIBIT 2005
`Biocon v. Novartis, IPR2020-01263
`Page 12 of 17
`
`

`

`Tabrizchi, R.
`
`26. Tabrizchi, R. Effect of chronic phenoxybenzamine treatment on α-mediated contraction. FASEB,
`7:A621, 1993.
`
`
`27. MacNicol, B.J., Lin, P.B. and Tabrizchi, R.. Altered excitation-contraction coupling in pulmonary
`hypertension. FASEB, 7:A329, 1993.
`
`
`28. Tabrizchi, R. Effect of chronic receptor blockade on excitation-contraction coupling. Clin. Invest.
`Med. 16:B72, 1993.
`
`
`29. Triggle, C.R. and Tabrizchi, R. Changes in vascular smooth muscle function in hypertension.
`Chinese Medical Journal 106:250-257, 1993.
`
`
`30. Lupichuk, S.M. and Tabrizchi,